Magazines and books

Publications and Presentations

Published data and presentations from medical conferences for Karyopharm’s investigational drug candidates

This page is intended to provide scientific information to scientific research professionals. Karyopharm’s drug candidates are investigational medicines and have not been approved by FDA, Health Canada, the European Medicines Agency (EMA) nor any other regulatory agency.

Featured Research

Multiple Myeloma

Diffuse Large B-cell Lymphoma (DLBCL)

Other Hematologic Malignancies

Solid Tumors